Viralgen and Axovia are set to form a partnership to progress the development and manufacturing of gene therapy for retinal ...

New Vericheck ddPCR Empty-Full Capsid Kits for AAV Serotypes 2 and 8 Provide Precise Measurement of Viral Titer and Capsid ...

Viralgen and Axovia Therapeutics are joining forces to advance the development and manufacture of an AAV9-based inv ...

This new tool, known as minimal, versatile genetic perturbation technology (mvGPT), combines the powers of gene editing, ...

Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in ...

As the percentage of the global population over 65 continues to increase, the popularity of anti-aging stocks is rising in ...

GTMI understands that successful transition from lab to market requires both a manufacturing process and a supply chain that are ready. Based on this premise, GTMI incorporates technology readiness ...

The NBA pays its players a lot of money. Almost every player who makes their way into a starting lineup at some point in their career earns generational wealth. Most of it is well deserved, as NBA ...

Nanoscope Therapeutics Inc., a biotechnology company committed to restoring vision in blind patients in real-world settings by developing and commercializing novel gene therapies for retinal ...